Trial intelligence / Profile preview

Xyzal vs Zyrtec in Dermatitis and Eczema

NCT00375713Phase 3Completed

Sponsor
UCB
Start
Oct 2005
Primary completion
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levocetirizine in dermatitis, Eczema, sponsored by UCB. Started Oct 2005; status: completed.

02

Drugs

levocetirizine
03

Conditions

dermatitisEczema

Beyond the preview

Go deeper on NCT00375713.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00375713.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call